K. A. Kunkel
Merck & Co., Inc., Rahway, NJ, USA (United States) · 5 works · 1,613 citations · h-index 4
Top works
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
- Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
- Characterization of [3H]pentagastrin binding in guinea pig gastric glands — An alternative convenient ligand for receptor binding assay
- ChemInform Abstract: Design of Nonpeptidal Ligands for a Peptide Receptor: Cholecystokinin Antagonists.
- ChemInform Abstract: Methods for Drug Discovery: Development of Potent, Selective, Orally Effective Cholecystokinin Antagonists.